Biotech Palatin Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update November 18, 2026
Biotech Pulmatrix Announces Third Quarter 2026 Financial Results and Progress on Merger November 18, 2026
Biotech Planet Green Holdings Acquires Registered Lactoferrin Immunity Chewable Tablet, Accelerating Its Entry into Growing Immune-Health Market November 18, 2026
Biotech MetaVia Announces Completion of Last Patient Visit in Extended 24-Week Phase 1 Part 3A Study of DA-1726 November 18, 2026
Biotech RedHill Biopharma (Nasdaq: RDHL) Highlights Strategic Transformation and Expanded Commercial Growth Strategy in Virtual Investor “What This Means” Segment November 17, 2026
Biotech Inhibrx Announces Updated Clinical Data for Ozekibart (INBRX-109) in Ewing Sarcoma November 17, 2026
Biotech Harbour BioMed’s Partner Spruce Biosciences Separates CRHX-101 Program into Adrenyx Biosciences, Advancing Development of Harbour BioMed-Originated Antibody through a Standalone Company November 17, 2026
Biotech Burning Rock Announces 2026 Annual General Meeting to be Held on December 22, 2026 November 17, 2026
Biotech Cancer Research UK and Dewpoint Therapeutics partner to advance potential first-in-class MYC condensate modulator into clinical development November 17, 2026